Eli Lilly has struck a deal to purchase genetic-medicine biotechnology firm Orna Therapeutics for as much as $2.4 billion in money.
Source link
Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion
Related Posts
CapitalG-backed Security startup Verkada hits $5.8 billion valuation
Filip Kaliszan, CEO of Verkada. Courtesy: Verkada Safety expertise startup Verkada has reached a $5.8 billion valuation after a brand…
How to Monitor Your Blood Pressure at Home (2026)
The Apple Watch shouldn’t be calibrated with a cuff. It takes 30 days of cardiac knowledge from the present optical…
The Best E-Readers for Amazon, Kobo and Other Platforms
Pros Easy to use, easy to read Enormous ecosystem of books Fast page turning Light weight Built-in screen reader 16GB…